CCNH expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.674800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.668800E-01
Normal-vs-Stage2
9.176200E-01
Normal-vs-Stage3
4.457200E-01
Normal-vs-Stage4
4.013600E-01
Stage1-vs-Stage2
6.153600E-01
Stage1-vs-Stage3
1.471800E-01
Stage1-vs-Stage4
6.188000E-01
Stage2-vs-Stage3
2.880600E-01
Stage2-vs-Stage4
3.881600E-01
Stage3-vs-Stage4
1.806000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.903000E-01
Normal-vs-AfricanAmerican
8.977200E-01
Normal-vs-Asian
2.810200E-01
Caucasian-vs-AfricanAmerican
5.721800E-01
Caucasian-vs-Asian
3.357900E-02
AfricanAmerican-vs-Asian
3.323400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.436000E-01
Normal-vs-Female
8.942200E-01
Male-vs-Female
7.892200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.666600E-01
Normal-vs-Age(41-60Yrs)
5.312000E-01
Normal-vs-Age(61-80Yrs)
9.447200E-01
Normal-vs-Age(81-100Yrs)
9.387800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.550200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.324800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.142800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.611520E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.714400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.107600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.398800E-01
Normal-vs-Daily Drinker
8.644800E-01
Normal-vs-Weekly Drinker
8.748800E-01
Normal-vs-Occasional Drinker
5.462000E-01
Normal-vs-Social Drinker
8.635200E-01
Non Drinker-vs-Daily Drinker
1.858390E-01
Non Drinker-vs-Weekly Drinker
6.702800E-01
Non Drinker-vs-Occasional Drinker
3.077700E-02
Non Drinker-vs-Social Drinker
2.343600E-01
Daily Drinker-vs-Weekly Drinker
5.604200E-01
Daily Drinker-vs-Occasional Drinker
3.188200E-01
Daily Drinker-vs-Social Drinker
9.877600E-01
Weekly Drinker-vs-Occasional Drinker
2.072600E-01
Weekly Drinker-vs-Social Drinker
6.003200E-01
Occasional Drinker-vs-Social Drinker
3.597200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.235600E-01
Normal-vs-Grade 2
8.396000E-02
Normal-vs-Grade 3
8.143800E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.272400E-01
Grade 1-vs-Grade 3
8.377000E-01
Grade 1-vs-Grade 4
2.235600E-01
Grade 2-vs-Grade 3
3.411600E-01
Grade 2-vs-Grade 4
8.396000E-02
Grade 3-vs-Grade 4
8.143800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.903400E-01
Normal-vs-NonDiabetic
9.727800E-01
Diabetic-vs-NonDiabetic
4.541200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.523800E-01
Normal-vs-NoPancreatitis
9.078400E-01
Pancreatitis-vs-NoPancreatitis
7.328800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.032200E-01
Normal-vs-N1
9.110600E-01
N0-vs-N1
6.159400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.048200E-01
Normal-vs-TP53-NonMutant
8.261400E-01
TP53-Mutant-vs-TP53-NonMutant
9.925600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
